Tirzepatide and Birth Control: How to Stay Protected

Tirzepatide can slow the absorption of oral contraceptives, particularly during the first weeks of treatment and after each dose step-up.
MHRA and NHS guidance advises adding a non-oral method (such as condoms) for four weeks when starting tirzepatide and for four weeks after every dose increase.
No equivalent reduction in oral contraceptive effectiveness has been identified for semaglutide (Wegovy) based on current NHS evidence.
Contraception is also relevant beyond absorption: MHRA advises using effective contraception throughout treatment and for a wash-out period before trying to conceive.

If you take tirzepatide and use oral contraceptives, there is a specific action to take: add a non-oral method of contraception — such as condoms — for the first four weeks of treatment and for four weeks after each dose increase. This is because tirzepatide slows gastric emptying, which can reduce how reliably the pill is absorbed. The decision about which contraception works alongside your treatment is worth making deliberately, before you start, not as an afterthought. These are prescription-only medicines, and a clinician needs to assess your full picture before treatment begins.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Understanding the practical decisions around contraception and tirzepatide

What gastric slowing actually means for the pill

Tirzepatide works partly by slowing how quickly food and liquid move from the stomach into the small intestine. That mechanism is central to how it reduces appetite. But the same effect applies to oral medicines taken at the same time, including the contraceptive pill.

Oral contraceptives are absorbed through the gut wall. When absorption is slower or less predictable, the plasma levels of the pill's hormones may not reach the concentrations they are designed to. In practice, this does not mean the pill stops working entirely, but it introduces enough uncertainty that UK clinical guidance treats it as a meaningful risk, particularly at the start of treatment and when the dose is increased.

Each dose increase effectively restarts the adjustment period. So the four-week protective window applies again at 5mg, again at 7.5mg, and so on through the titration schedule. If you tend to reach each new dose around the same time each month (or if a dose increase coincides with a holiday or a busy patch when it is easy to forget) it is worth planning your additional contraception well in advance, not on the day.

This information is drawn from NHS Inform Scotland's guidance on diabetes and weight-loss medication and the NHS England weight-management injections guidance.

Which contraceptive methods are affected and which are not

The concern here is specific to oral contraceptives, tablets and pills that pass through the stomach and depend on gut absorption. Non-oral hormonal methods are not subject to the same mechanism. The coil (both hormonal and copper), the implant, the contraceptive patch, the injection and the hormonal IUS all deliver hormones directly or act locally; they bypass the gut entirely.

If you already use a contraceptive implant, you do not need to add an additional method when starting tirzepatide. The same applies to the hormonal coil. These methods are unaffected by changes in gastric emptying speed.

Condoms are the simplest additional method for people on the pill who want to cover the four-week window without switching method. They are also the method most likely to be immediately to hand. Your prescriber can discuss the options that suit your situation, what matters is that you have a plan before the first pen is used, not midway through the first month.

If you are unsure which category your contraception falls into, our guide to how Mounjaro affects birth control pills explains the absorption detail, and your prescriber or GP can advise on your specific method.

The wider contraception picture: conceiving on tirzepatide

The four-week absorption window is the most time-sensitive issue, but it is not the only contraception consideration. MHRA guidance advises that women of childbearing age use effective contraception throughout treatment with tirzepatide, and for a period after stopping, before trying to conceive. Tirzepatide is not recommended in pregnancy, during breastfeeding, or in people who are actively trying to become pregnant.

This wash-out recommendation exists because tirzepatide's effects on the developing foetus have not been fully established in human studies. The prescriber reviewing your consultation will ask about pregnancy plans as part of the clinical assessment, it is a routine and important part of the conversation, not an intrusive one.

For context on how tirzepatide works as a treatment and what the full titration schedule looks like, the tirzepatide overview covers the mechanism and licensed indications in more detail. And if you are weighing up which treatment suits your situation, the weight-loss treatment overview sets out the options available through nume.

HRT and tirzepatide: a related point worth knowing

The same gastric-slowing mechanism that affects oral contraceptive absorption also applies to oral HRT. NHS England advises that women taking oral HRT alongside tirzepatide consider switching to a transdermal form (patches or gels) so that oestrogen absorption is not affected. This is a conversation to have with your GP or gynaecologist, ideally before treatment starts rather than after the first dose.

If you are using tirzepatide for blood sugar control alongside weight management, the tirzepatide and blood sugar page covers that intersection. Cost is a practical factor for many people beginning treatment; the Mounjaro pricing page explains what is included in a private prescription and how private treatment is structured.

The bottom line on contraception and tirzepatide is straightforward: if you use the pill, add a barrier method for the first four weeks and for four weeks after each dose increase, and our page on using Mounjaro with birth control covers the practical steps in full. If you use a non-oral method, no change is needed. Your prescriber confirms the right approach for your situation as part of the clinical review, and aftercare is there if questions come up later.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions